Start with records, testing, and physician review.
Before any treatment decision, Cellforce One Clinic Tokyo works through your records, imaging, and a physician review — in that order. This page explains the framework behind that process: filed provision plans, self-pay care, physician judgment, informed consent, and cell-processing governance.
Regenerative-medicine provision plans filed with the Minister of Health, Labour and Welfare.
Related cell-processing and operational contracts managed as part of the provider framework.
Plan numbers are shown as framework information, not as outcome claims.
MSC / Chronic Pain
MSC consultation for chronic pain. Intravenous infusion may be included when the physician determines suitability.
Plan numbers: PB3240161 / PB3250154.
MSC / Osteoarthritis
MSC consultation for osteoarthritis. Intra-articular administration may be included for selected cases after physician review.
Plan numbers: PB3240166 / PB3250155.
NK Cell Therapy
Autologous NK cell therapy information. Individual suitability is reviewed by the physician.
Plan number: PB3250244.
Filed plans, annual reporting, and necessary filing management.
Cellforce One Clinic Tokyo files regenerative-medicine provision plans with the Minister of Health, Labour and Welfare under Japan's Act on Safety of Regenerative Medicine. The clinic manages five provision plans, six related cell-processing / operational contracts, annual or periodic reporting, and necessary filing management.
This describes the provider framework. It is not a national efficacy endorsement and does not promise individual treatment outcomes.
The next step is not a sale. It is a physician review.
Records
We start with your MRI, blood tests, medical history, medications, cancer history, and previous treatment records.
Consent
Costs, main risks, alternatives, and the expected schedule are explained in full before any procedure is considered.
Decision
The physician determines whether NK, MSC, another option, referral, follow-up, or no regenerative-medicine procedure is appropriate.
Public registry and official channels.
These links point to Japan's public registry pages for filed regenerative-medicine provision plans and to the clinic's official YouTube / Instagram channels. Registry publication is a reference for filed provision-plan information; it is not evidence of individual treatment outcomes or absence of risk.